Celecoxib versus diclofenac and omeprazole to prevent recurrent ulcer bleeding

N Engl J Med. 2003 Jun 12;348(24):2464-6; author reply 2464-6.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal*
  • Anti-Ulcer Agents / therapeutic use
  • Celecoxib
  • Contraindications
  • Cyclooxygenase Inhibitors
  • Diclofenac*
  • Drug Therapy, Combination
  • Humans
  • Kidney Diseases / chemically induced*
  • Omeprazole / therapeutic use
  • Peptic Ulcer Hemorrhage / prevention & control*
  • Pyrazoles
  • Risk Factors
  • Secondary Prevention
  • Sulfonamides*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Diclofenac
  • Celecoxib
  • Omeprazole